Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient’s own blood for bedside procedures.
2003 – Foundation
2010 – RegenKit first approval in bone graft
2013 – A new state-of-theart laboratory in Lausanne
2014 – Cellular Matrix first approval
2015 – Launch of Cellular Matrix in Europe
Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.